Senseonics Holdings Inc., of Germantown, Md., scored a win with the FDA, which approved the company's Eversense continuous glucose monitoring (CGM) system for people with diabetes. The system features an implantable glucose sensor and provides long-term continuous monitoring for up to three months. Read More
